As such, we conducted in vivo testing of our proposed fibroblast therapy in cynomolgus monkeys
The pre-specified secondary outcomes were (1) all cause-mortality and (2) incidence of a cardiovascular composite event outcome that included: first occurrence of acute myocardial infarction, cardiac arrest or ventricular fibrillation, acute stroke, or coronary revascularization, as previously described and validated using validated International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) and 10th Revision, Clinical Modification (ICD-10-CM) and procedure codes 52,53,54
Jauhari A, Singh T, Mishra S et al (2020) Coordinated action of miR-146a and parkin gene regulate rotenone-induced neurodegeneration
That first week of fumbling around with needles feels like a lifetime ago
L-Carnitine is a nutrient that is derived from the amino acids lysine and methionine
What is a compounded medication